ADVERTISEMENT
Poster
CS-018
A Case Series for Management of Complicated Diabetic Foot Wounds
Introduction: It is well documented that diabetic foot ulcers are a complication that
impacts healthcare systems and patient quality of life. Even more problematic are patients
with significant co-morbidities and a history of complications. Traditional Standard of
Care (SOC) treatments are inadequate for many of these patients, necessitating advanced
wound care products like human placental membranes. These products are intended as
covering for acute and chronic wounds. We present here a series of four complicated
patients with difficult-to-heal diabetic foot ulcers. Human placental membrane which was
retention-processed (RE-AC) had a profound effect on these patients.Methods:Case 1 involved a diabetic patient with previous 5 th partial ray
amputation presenting with macerated, undermined ulcers of the foot. Case 2 is a diabetic
hemodialysis patient who received kidney and pancreas transplants. The patient has
osteomyelitis of the foot, gout and limited vascularity at a full-thickness ulcer of the toe.
Case 3 involves a diabetic patient with multiple amputations who developed necrosis on
the right foot down to bone.
RE-AC (AW2) was applied to these wounds every 7 days.Results:The application of RE-AC proved to be very effective in the treatment of these patients. The
patients demonstrated clinical improvement with within one to three applications of the skin
substitute. Two patients went on to complete closure. Discussion: Even in the most challenging cases, the use of this RE-AC, as a wound covering, offers
significant improvement in the timeline to closure, which reduces the risk for limb threatening
infection, and allowing the patient to return to a more normal lifestyle. This translates to reduced
treatment costs, and optimized resource utilization in a healthcare setting.
Diabetic foot ulcers, DFU, placental membrane, retrospective, amnion chorion, ACReferences: